APR 22, 2020 8:03 PM PDT

Preventing Blindness in Premature Births

WRITTEN BY: Nouran Amin

The premature birth of infants places them at risk for blindness because of retinopathy of prematurity (ROP). To prevent ROP, infants could be treated with a dose of Avastin (bevacizumab). The conclusions were according to a dose-finding study published in JAMA Ophthalmology.

"In the current study, we found that 0.004 mg of Avastin -- a dose that's merely 0.6% of the dose used in the 2011 study of Avastin for ROP -- may be the lower limit to be effective for most infants with ROP," says Dr. David Wallace of Indiana University School of Medicine. “The findings set the stage for a randomized controlled trial comparing long-term effects of low-dose Avastin with laser therapy for treating ROP.”

Learn more about ROP:

The reason preterm babies are at risk for blindness is because of the possibility of abnormal blood vessel growth in the retina tissue. Vessel growth leads to detachment of the retina—and eventually ROP-related vision loss. With Avastin use, abnormal blood vessel growth will be prevented by the inhibition of the protein called vascular endothelial growth factor (VEGF).

Current treatments for ROP include laser and cryo-therapeutics but Avastin may provide a better and effective option. Avastin was approved by the U.S. Food and Drug Administration in 2004 for treating cancer,

"As a faster and easier treatment option, anti-VEGF eye injections were a welcomed alternative to laser therapy for treating severe ROP," adds Dr. Wallace. "But we know that anti-VEGF agents injected into the eye also get into the bloodstream, and doctors worry that inhibiting VEGF systemically could interfere with normal development of brain, lung, bone, and kidney tissues.”

Source: Science Daily

 

 

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUL 28, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUL 28, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
JUL 08, 2022
Cannabis Sciences
The Latest Research on Cannabis Social Equity Programs
JUL 08, 2022
The Latest Research on Cannabis Social Equity Programs
Cannabis social equity programs are designed to increase licensure and employment opportunities for lower income and BIP ...
JUL 01, 2022
Drug Discovery & Development
Paper-thin Device Treats Pain and then Dissolves in Body
JUL 01, 2022
Paper-thin Device Treats Pain and then Dissolves in Body
Researchers have developed a biocompatible, implantable device that relieves pain and harmlessly dissolves when no longe ...
JUL 03, 2022
Cell & Molecular Biology
Reversing the Spread of a Deadly Cancer
JUL 03, 2022
Reversing the Spread of a Deadly Cancer
One of the deadliest types of cancer is pancreatic ductal adenocarcinoma (PDAC); the survival rate at five years after d ...
JUL 15, 2022
Cannabis Sciences
Cannabis Legalization's Impact on Foster Care Placements
JUL 15, 2022
Cannabis Legalization's Impact on Foster Care Placements
A study published in the journal Economic Inquiry analyzed the potential impacts of federal cannabis legalization on fos ...
AUG 07, 2022
Drug Discovery & Development
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
AUG 07, 2022
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
A singular injection of a monoclonal antibody treatment candidate has been shown as safe and highly protective in US adu ...
Loading Comments...